Newsroom

April 10, 2020

FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agentas a Diagnostic for the Management of Eosinophilic Esophagitis

NEXEOS BIO White Logo 2020MAR16 F CMYK-0

© 2020 Copyright NexEos Bio. All rights reserved.